U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Ip S, Glicken S, Kulig J, et al. Management of Neonatal Hyperbilirubinemia. Rockville (MD): Agency for Healthcare Research and Quality (US); 2003 Jan. (Evidence Reports/Technology Assessments, No. 65.)

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Management of Neonatal Hyperbilirubinemia

Management of Neonatal Hyperbilirubinemia.

Show details

Evidence Tables

Evidence Table 1. Question 1 - Studies evaluating association of neonatal hyperbilirubinemia to neurodevelopmental outcomes - Part I

Evidence Table 1. Question 1 - Studies evaluating association of neonatal hyperbilirubinemia to neurodevelopmental outcomes - Part II

Evidence Table 1. Question 1 - Studies evaluating association of neonatal hyperbilirubinemia to neurodevelopmental outcomes - Part II

Evidence Table 1A. Question 2 - Study evaluating evidence for effect modification - Part I

Evidence Table 1A. Question 2 - Study evaluating evidence for effect modification - Part II

Evidence Table 1A. Question 2 - Study evaluating evidence for effect modification - Part III

Evidence Table 2 . Question 3: Section I - Treatment Effect on Decreasing Bilirubin Levels and Changing Auditory Brainstem Response in Term or Near-Term Jaundiced Infants - Part I

Evidence Table 2. Question 3: Section I - Treatment Effect on Decreasing Bilirubin Levels and Changing Auditory Brainstem Response in Term or Near-Term Jaundiced Infants - Part II

Evidence Table 2. Question 3: Section I - Treatment Effect on Decreasing Bilirubin Levels and Changing Auditory Brainstem Response in Term or Near-Term Jaundiced Infants - Part III

Evidence Table 3. Question 3: Section II - Studies evaluating treatments for neonatal hyperbilirubinemia in relation to later neurodevelopmental outcomes - Part I

Evidence Table 3. Question 3: Section II - Studies evaluating treatments for neonatal hyperbilirubinemia in relation to later neurodevelopmental outcomes - Part II

Evidence Table 3. Question 3: Section II - Studies evaluating treatments for neonatal hyperbilirubinemia in relation to later neurodevelopmental outcomes - Part III

Evidence Table 4. Question 4 - Studies evaluating the accuracy of various strategies for predicting hyperbilirubinemia - Part I

Evidence Table 4. Question 4 - Studies evaluating the accuracy of various strategies for predicting hyperbilirubinemia - Part II

Evidence Table 4. Question 4 - Studies evaluating the accuracy of various strategies for predicting hyperbilirubinemia - Part III

Evidence Table 5.1. Question 5 - Studies evaluating the accuracy of AirShields Minolta bilirubinometer - Part I

Evidence Table 5.1. Question 5 - Studies evaluating the accuracy of AirShields Minolta bilirubinometer - Part II

Evidence Table 5.1. Question 5 - Studies evaluating the accuracy of AirShields Minolta bilirubinometer - Part III

Evidence Table 5.1. Question 5 - Studies evaluating the accuracy of AirShields Minolta bilirubinometer - Part IV

Evidence Table 5.2. Question 5 - Studies evaluating the accuracy of BiliCheck™ - Part I

Evidence Table 5.2. Question 5 - Studies evaluating the accuracy of BiliCheck™ - Part II

Evidence Table 5.2. Question 5 - Studies evaluating the accuracy of BiliCheck™ - Part III

Evidence Table 5.2 . Question 5 - Studies evaluating the accuracy of BiliCheck™ - Part IV

Evidence Table 5.3 . Question 5 - Studies evaluating the accuracy of Ingram Icterometer - Part I

Evidence Table 5.3. Question 5 - Studies evaluating the accuracy of Ingram Icterometer - Part II

Evidence Table 5.3. Question 5 - Studies evaluating the accuracy of Ingram Icterometer - Part III

Evidence Table 5.3. Question 5 - Studies evaluating the accuracy of Ingram Icterometer - Part IV

Evidence Table 5.4. Question 5 - Studies evaluating the accuracy of Colormate III - Part I

Evidence Table 5.4. Question 5 - Studies evaluating the accuracy of Colormate III - Part II

Evidence Table 5.4. Question 5 - Studies evaluating the accuracy of Colormate III - Part III

Evidence Table 5.4. Question 5 - Studies evaluating the accuracy of Colormate III - Part IV

Evidence Table 6.1. Clinical Data on Term Newborns with Idiopathic Jaundice Who Had Kernicterus Part I

Evidence Table 6.1. Clinical Data on Term Newborns with Idiopathic Jaundice Who Had Kernicterus Part II

Evidence Table 6.2. Clinical Data on Term Newborns with Comorbid Factors Who Had Kernicterus Part I

Evidence Table 6.2. Clinical Data on Term Newborns with Comorbid Factors Who Had Kernicterus Part II

Views

  • PubReader
  • Print View
  • Cite this Page

Other titles in these collections

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...